Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • Θα στείλουμε Γενική Ούρων και Καλλιέργεια, καθώς και αιματολογικές εξετάσεις. [undo]
  • Προσέλευση [undo]
  • [undo]
  • Allow the family member to stay on screen without clarifying their role [undo]
  • Node 1: Introduction [undo]
  • Observation [undo]
  • Σαλβουταμόλη 5mg και Βρωμιούχο ιπρατρόπιο 250μg με νεφελοποιητή [undo]
  • Εργαστηριακά [undo]
  • Ζητάς από τη νοσοκόμα να περάσει αμέσως το παιδί σε ένα εξεταστήριο ώστε να το εκτιμήσεις [undo]
  • LAB SAFETY [undo]
  • Καλείς επειγόντως τον αναισθησιολόγο [undo]
  • Εργαστηριακά [undo]
  • Insulin [undo]
  • Εισαγωγή [undo]
  • ΠΑΡΟΥΣΙΑΣΗ ΠΕΡΙΣΤΑΤΙΚΟΥ [undo]
  • Ανακεφαλαίωση [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21088
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway